Innovent Presents Phase 1b Clinical Data of IBI188 (Anti-CD47 Monoclonal Antibody) at the 2022 American Society of Hematology Annual Meeting

/PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes...

Related Keywords

China ,Taiwan ,United States ,Hong Kong ,Macau ,Suzhou ,Jiangsu ,Rhui Zhou ,Guangdong ,American ,Innovent Biologics ,Selpercatinib Eli Lilly ,Adimab Incyte ,Miao ,Eli Lilly ,American Society Of Hematology ,First Affiliated Hospital Of Suzhou University ,Prnewswire Innovent Biologics Inc ,Md Anderson Cancer Center ,Incyte Corporation ,Annual Meeting ,Updated Results ,Objective Response Rate ,First Affiliated Hospital ,Suzhou University ,Senior Vice President ,Mainland China ,Main Board ,Stock Exchange ,Hong Kong Limited ,Cancer Center ,